Aortic stenosis is a valvular heart disease resulting in reduction of blood flow to the body and making the heart work harder. The heart may weaken causing chest pain, fatigue and shortness of breath.
Pulmonary atresia with intact interventricular septum Ramachandra Barik
PA/IVS is a rare congenital cardiac defect that consists of atresia of the pulmonary valve resulting in an absent connection between the right ventricular outflow tract (RVOT) and pulmonary arteries, and an intact ventricular septum that allows no connection between the right and left ventricles
A detailed discussion on embryogenesis of heart and ennumeration of all congenital diseases and description of cyanotic congenital heart disease , each disease in detail.
Patent ductus arteriosus (PDA) is a congenital disorder in the heart wherein a neonate's ductus arteriosus fails to close after birth. Early symptoms are uncommon, but in the first year of life include increased work of breathing and poor weight gain. With age, the PDA may lead to congestive heart failure if left uncorrected. The ductus arteriosus is a normal fetal blood vessel that closes soon after birth. In a patent ductus arteriosus (PDA) the vessel does not close and remains "patent" (open) resulting in irregular transmission of blood between two of the most important arteries close to the heart, the aorta and the pulmonary artery. PDA is common in neonates with persistent respiratory problems such as hypoxia, and has a high occurrence in premature children. In hypoxic newborns, too little oxygen reaches the lungs to produce sufficient levels of bradykinin and subsequent closing of the DA. Premature children are more likely to be hypoxic and thus have PDA because of their underdeveloped heart and lungs.
A patent ductus arteriosus allows a portion of the oxygenated blood from the left heart to flow back to the lungs by flowing from the aorta (which has higher pressure) to the pulmonary artery. If this shunt is substantial, the neonate becomes short of breath: the additional fluid returning to the lungs increases lung pressure to the point that the neonate has greater difficulty inflating the lungs. This uses more calories than normal and often interferes with feeding in infancy. This condition, as a constellation of findings, is called congestive heart failure.
In some cases, such as in transposition of the great vessels (the pulmonary artery and the aorta), a PDA may need to remain open. In this cardiovascular condition, the PDA is the only way that oxygenated blood can mix with deoxygenated blood. In these cases, prostaglandins are used to keep the patent ductus arteriosus open
TAPVC defines the anomaly in which the pulmonary veins have no connection with the left atrium. Rather, the pulmonary veins connect directly to one of the systemic veins (TAPVC) or drain in to right atrium.
A PFO or ASD is present essentially in those who survive after birth
When pulmonary veins drain anomalously into the right atrium either because of complete absence of the interatrial septum or malattachment of the septum primum , then it is known as total anomalous pulmonary venous drainage.
When some or all of the pulmonary veins drain anomalously in to RA or its tributaries without being abnormally connected, the terms partially anomalous pulmonary venous drainage (PAPVD) or totally anomalous pulmonary venous drainage (TAPVD) with normal pulmonary venous connections are used.
Persistent truncus arteriosus (or patent truncus arteriosus), also known as Common arterial trunk, is a rare form of congenital heart disease that presents at birth. In this condition, the embryological structure known as the truncus arteriosus fails to properly divide into the pulmonary trunk and aorta. This results in one arterial trunk arising from the heart and providing mixed blood to the coronary arteries, pulmonary arteries, and systemic circulation
Aortic stenosis is a valvular heart disease resulting in reduction of blood flow to the body and making the heart work harder. The heart may weaken causing chest pain, fatigue and shortness of breath.
Pulmonary atresia with intact interventricular septum Ramachandra Barik
PA/IVS is a rare congenital cardiac defect that consists of atresia of the pulmonary valve resulting in an absent connection between the right ventricular outflow tract (RVOT) and pulmonary arteries, and an intact ventricular septum that allows no connection between the right and left ventricles
A detailed discussion on embryogenesis of heart and ennumeration of all congenital diseases and description of cyanotic congenital heart disease , each disease in detail.
Patent ductus arteriosus (PDA) is a congenital disorder in the heart wherein a neonate's ductus arteriosus fails to close after birth. Early symptoms are uncommon, but in the first year of life include increased work of breathing and poor weight gain. With age, the PDA may lead to congestive heart failure if left uncorrected. The ductus arteriosus is a normal fetal blood vessel that closes soon after birth. In a patent ductus arteriosus (PDA) the vessel does not close and remains "patent" (open) resulting in irregular transmission of blood between two of the most important arteries close to the heart, the aorta and the pulmonary artery. PDA is common in neonates with persistent respiratory problems such as hypoxia, and has a high occurrence in premature children. In hypoxic newborns, too little oxygen reaches the lungs to produce sufficient levels of bradykinin and subsequent closing of the DA. Premature children are more likely to be hypoxic and thus have PDA because of their underdeveloped heart and lungs.
A patent ductus arteriosus allows a portion of the oxygenated blood from the left heart to flow back to the lungs by flowing from the aorta (which has higher pressure) to the pulmonary artery. If this shunt is substantial, the neonate becomes short of breath: the additional fluid returning to the lungs increases lung pressure to the point that the neonate has greater difficulty inflating the lungs. This uses more calories than normal and often interferes with feeding in infancy. This condition, as a constellation of findings, is called congestive heart failure.
In some cases, such as in transposition of the great vessels (the pulmonary artery and the aorta), a PDA may need to remain open. In this cardiovascular condition, the PDA is the only way that oxygenated blood can mix with deoxygenated blood. In these cases, prostaglandins are used to keep the patent ductus arteriosus open
TAPVC defines the anomaly in which the pulmonary veins have no connection with the left atrium. Rather, the pulmonary veins connect directly to one of the systemic veins (TAPVC) or drain in to right atrium.
A PFO or ASD is present essentially in those who survive after birth
When pulmonary veins drain anomalously into the right atrium either because of complete absence of the interatrial septum or malattachment of the septum primum , then it is known as total anomalous pulmonary venous drainage.
When some or all of the pulmonary veins drain anomalously in to RA or its tributaries without being abnormally connected, the terms partially anomalous pulmonary venous drainage (PAPVD) or totally anomalous pulmonary venous drainage (TAPVD) with normal pulmonary venous connections are used.
Persistent truncus arteriosus (or patent truncus arteriosus), also known as Common arterial trunk, is a rare form of congenital heart disease that presents at birth. In this condition, the embryological structure known as the truncus arteriosus fails to properly divide into the pulmonary trunk and aorta. This results in one arterial trunk arising from the heart and providing mixed blood to the coronary arteries, pulmonary arteries, and systemic circulation
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
5. In the presence of an atrial septal
defect, the difference in
compliance between the (RA+ RV)
as compared to the (LA+LV),
combined with the size of the
defect itself, allows for a “shunt” of
flow (“y”) of “red” (oxygenated)
blood from the left side of the heart
to the right side (deoxygenated).
Systemic venous return of pure
deoxygenated blood (“x”) is
increased by the oxygenated
shunted blood (“y”) to increase
volume of blood (“x + y”) in the RA,
RV, and total blood flow
to the lungs. If the volume or the
sequelae of the shunted blood is
suffcient, RA and RV can dilate
(hashed lines), and arrhythmias or
shortness of breath (and
occasionally pulmonary
hypertension) can ensue.
Jameson, J. L. (2018). Harrison’s Principles of Internal Medicine (20th ed.). New York: McGraw-Hill
6. Atrial Septal Defect
Pathophysiology:
Left-to-right shunting is determined by the size of the defect and diastolic
properties of the heart
↑ Age → DM, HTN, atherosclerosis → ↓ compliance of left chambers →
↑ shunting → ↑ symptoms
Symptoms:
Mostly asymptomatic till late adulthood, often incidentally diagnosed
Exercise intolerance, arrhythmia, dyspnea with exertion
Children: Failure to thrive, frequent respiratory infections
7. Atrial Septal Defect
Physical Examination:
Classical finding: Wide, fixed splitting of S2
Due to prolonged RV ejection & increased pulmonary artery capacitance
Murmurs:
Increased blood flow across pulmonary valve → systolic ejection murmur at 3rd ICS
Increased blood flow across tricuspid valve → mid-diastolic murmur at lower right
sternum
Right ventricular heave (due to RVH)
9. ASD: Investigations
Chest X-ray:
Enlarged heart
Enlarged pulmonary artery
Increased pulmonary vascular markings, central plethora
ECG:
Right axis deviation in secundum defect
Hallmark of primum defect is Left axis deviation
RVH, RBBB patterns may be seen
Echocardiography:
RVH
Valve anatomy, flow direction
10. ASD: Complications
Right heart dilation:
Risk factor for progression toward symptomatic right heart failure, atrial arrhythmias, and
potential development of pulmonary hypertension
Therefore, these patients must be offered ASD closure
Pulmonary hypertension:
Pulmonary vascular disease leasing to pul. hypertension occurs in 10% of cases
Eisenmenger syndrome (ES) is a rare complication
11. ASD: Types
Secundum type:
Most common type
In the region of fossa ovalis
Different from patent foramen ovale (PFO),
which is the persistence of the flap valve of
fossa ovalis
Can be closed percutaneously, except if large in
size, inadequate tissue rims or associated
TAPVC
12. ASD: Types
Primum ASD:
Deficiency in AV canal portion of the atrial
septum
Always associated with abnormal development
of AV valves, most commonly resulting in cleft in
mitral valve
Coronary sinus defect:
Rare, opening between coronary sinus & left atrium
13. ASD: Types
Sinus venosus defect:
Not a defect in the atrial septum
Defect between right superior vena caval-atrial
junction & right upper pulmonary veins
Or less commonly, the inferior vena caval-atrial
junction and the right lower pulmonary veins
Management:
Percutaneous closure for secundum ASDs
Surgical closure is required for primum ASDs,
coronary sinus & sinus venosus defects.
15. Ventricular Septal Defect
Most common congenital heart defect recognized at birth
But only 10% of CHD in adult as high rate of spontaneous closure of small
VSDs in early years of life
Large VSDs – cause symptoms of heart failure & poor somatic growth, have a
higher risk of pulmonary hypertension & Eisenmenger syndrome
16. In the presence of a ventricular
septal defect, the difference in
pressure and outflow resistance in
systole (and the difference in
compliance in diastole) between
the RV and LV, combined with the
size of the defect itself, allow for a
“shunt” of flow (“y”) of “red”
(oxygenated) blood from the left
side of the heart to the right side
(deoxygenated). Systemic venous
return of pure deoxygenated blood
(“x”) is increased by the
oxygenated shunted blood
(“y”) to increase volume of blood
(“x + y”) through the outflow of the
RV into the lungs, and in the left
atrium and left ventricle. If the
volume or the sequelae of the
shunted blood is suffcient, LA and
LV can dilate (hashed lines), and
arrhythmias or shortness of breath
(and occasionally pulmonary
hypertension) can ensue.
Jameson, J. L. (2018). Harrison’s Principles of Internal Medicine (20th ed.). New York: McGraw-Hill
17. Ventricular Septal Defect
Pathophysiology:
Left-to-right shunt as long as pulmonary vascular resistance is lower than system
(may reverse if increased – Eisenmenger syndrome)
Clinical Features:
Mostly asymptomatic
Growth failure, recurrent respiratory infections
Congestive heart failure
Risk of infective endocarditis increased
18. Ventricular Septal Defect
Clinical Examination:
Parasternal thrill
Pansystolic murmur at lower left sternal edge (loud if small defect)
Large VSD → Increased flow across pulmonary valve → Ejection systolic
murmur
Loud P2 if pulmonary hypertension develops
19. VSD: Classification
Membranous type:
Most common, also called peri-membranous or outlet
type
Muscular type:
Often pressure and flow restricted, resulting in no
significant hemodynamic consequence
Atrioventricular canal defects:
Also referred to as inlet defects
Located in the crux of the heart
Associated with abnormalities of the AV valve leaflets
20. VSD: Classification
Sub-pulmonary type:
Also known as conal septal defects
Commonly associated with prolapse of the right
coronary cusp and aortic insufficiency
21. VSD: Investigations
Chest X-ray:
Cardiomegaly, enlarged LA & LV
Enlarged PA, increased pulmonary vascular markings
Pulmonary edema may be seen
ECG:
Extreme left axis is characteristic, biventricular hypertrophy
Echocardiography:
Determines chamber sizes and pressures
Cardiac catheterization:
Oxygen content, PA pressure & size, number of defects
22. VSD: Management
Majority close spontaneously before 1 year of age, less than 10% require
surgery
Treatment:
Surgical closure before pulmonary vascular changes become irreversible
Endocarditis prophylaxis
Heart failure management: Diuretics, ACEIs
Prognosis:
Outcome for adults with small VSDs without evidence of ventricular dilation or pulmonary
hypertension is generally excellent
24. In the presence of a patent ductus
arteriosus, the difference in
pressure and resistance in both
systole and diastole between
the pulmonary arteries and the
aorta, combined with the size of
the ductus itself, allow for a “shunt”
of flow (“y”) of “red” (oxygenated)
blood from the aorta to the
pulmonary arteries
(deoxygenated). Systemic venous
return of pure deoxygenated blood
(“x”) is increased by the
oxygenated shunted blood (“y”) to
increase volume of blood (“x + y”)
in the lungs, the left atrium, the left
ventricle, and out the aortic valve.
If the volume or the sequelae of
the shunted blood is suffcient, LA
and LV can dilate (hashed lines),
and arrhythmias or shortness of
breath (and occasionally
pulmonary hypertension) can
ensue.
Jameson, J. L. (2018). Harrison’s Principles of Internal Medicine (20th ed.). New York: McGraw-Hill
25. Jameson, J. L. (2018). Harrison’s Principles of Internal Medicine (20th ed.). New York: McGraw-Hill
26. Patent Ductus Arteriosus
Courses between the aortic isthmus and the origin of one of the branch
pulmonary arteries
Small PDAs → often silent to auscultation, and do not cause hemodynamic
changes
Large PDAs will lead to left heart dilation and may lead to chronically elevated
pulmonary vascular resistance, including the potential for Eisenmenger
Syndrome.
Clinical features:
Depend on size & direction of flow
Slow growth, recurrent LRTIs
27. Patent Ductus Arteriosus
Classic continuous “machinery” murmur:
Best heard below left clavicle
Typically extends from systole past S2 into diastole, reflecting flow turbulence
and gradient between the aorta and the pulmonary arteries (resulting in L→R
shunting)
Bounding pulse
28. Patent Ductus Arteriosus
Investigations:
Chest X-ray: Cardiomegaly, increased pulmonary vascularity
ECG: Biventricular hypertrophy
Echocardiography: visualizes PDA, Doppler shows turbulence
Cardiac catheterization: Shows PA pressures & oxygen saturations
Treatment:
Infective endocarditis prophylaxis as long as duct is patent
Indomethacin, a PG-E1 inhibitor, may close the PDA
Surgical ligation / coiling / clipping / division may be done
30. Eisenmenger Syndrome
Final common pathway for all significant left to right
shunts
Unrestricted pulmonary blood flow leads to
pulmonary vaso-occlusive disease (PVOD) after
which reversal of shunt occurs and cyanosis
develops
Generally need Qp : Qs ratio of > 2:1 (pulmonary to
systemic blood flow ratio determined by Doppler)
Management:
34. Coarctation of Aorta
Shelf-like obstruction at the level of the
descending aorta that passes just posterior
to the junction of the main and left PA
98% are at a segment adjacent to ductus
arteriosus
35. Coarctation of Aorta
Poor prognosis if unrepaired
Physical Examination:
Lower extremity blood pressure and pulses are lower than, and delayed in timing,
to the upper extremity (unless significant aortic collaterals have developed)
A continuous murmur over the scapula may be present, due to the collateral blood
flow
Chest X-ray: Rib-notching is pathognomonic
37. Coarctation of Aorta Associations:
Bicuspid aortic valve (typically with right-left
commissural fusion) is a common association.
Descending or aortic aneurysm / enlargement
LV diastolic & systolic heart failure
Accelerated coronary or cerebral
atherosclerosis
Cerebral aneurysm formation
Recurrence of coarctation after repair
Turner syndrome in females (short stature,
webbed neck, lymphedema, primary
amenorrhea)
38. Coarctation of Aorta
Surgical correction:
Patch aortoplasty with removal of segment
and end-to-end anastomosis
Bypass tube grafting around segment
Prognosis:
Good prognosis on surgical repair, but remain at
risk for systemic hypertension, premature
atherosclerosis, LV failure, as well as aortic
aneurysm, dissection, and recurrent coarctation
39. Others
Other obstructive acyanotic congenital heart diseases include pulmonary stenosis &
aortic stenosis
Pulmonary stenosis:
No symptoms in mild or moderate lesions. Cyanosis, RVH, right heart failure seen with
severe lesions.
High pitched systolic ejection murmur heard, loudest at 2nd left ICS. Ejection click often
present
Oligemic lung fields on chest x-ray
Aortic stenosis:
Most common obstructive type, usually asymptomatic in children
May cause severe heart failure in infants
Harsh systolic murmur and thrill along left sternal border, systolic ejection click heard.